RESTATEMENT (Details 1) - USD ($) |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Feb. 28, 2018 |
Feb. 28, 2017 |
Feb. 28, 2018 |
Feb. 28, 2017 |
|||||
| Consolidated Statements of Operations | ||||||||
| Research and development | [1] | $ 647,467 | $ 680,543 | |||||
| Total Operating Expenses | 798,464 | [1] | $ 11,995 | 1,075,521 | [1] | $ 21,512 | ||
| Loss from Operations | (798,464) | [1] | (11,995) | (1,075,521) | [1] | (21,512) | ||
| NET LOSS | (798,464) | [1] | (13,011) | (1,075,521) | [1] | (22,528) | ||
| TOTAL COMPREHENSIVE LOSS | $ (799,718) | [1] | $ (13,011) | $ (1,077,800) | [1] | $ (22,528) | ||
| Basic and Diluted Loss per Common Share (in dollars per share) | $ (0.07) | [1] | $ (0.00) | $ (0.10) | [1] | $ (0.00) | ||
| Originally Reported | ||||||||
| Consolidated Statements of Operations | ||||||||
| Research and development | $ 477,357 | $ 510,433 | ||||||
| Total Operating Expenses | 628,354 | 905,411 | ||||||
| Loss from Operations | (628,354) | (905,411) | ||||||
| NET LOSS | (628,354) | (905,411) | ||||||
| TOTAL COMPREHENSIVE LOSS | $ (629,608) | $ (907,690) | ||||||
| Basic and Diluted Loss per Common Share (in dollars per share) | $ (0.05) | $ (0.08) | ||||||
| Restatement Adjustment | ||||||||
| Consolidated Statements of Operations | ||||||||
| Research and development | $ 170,110 | $ 170,110 | ||||||
| Total Operating Expenses | 170,110 | 170,110 | ||||||
| Loss from Operations | (170,110) | (170,110) | ||||||
| NET LOSS | (170,110) | (170,110) | ||||||
| TOTAL COMPREHENSIVE LOSS | $ (170,110) | $ (170,110) | ||||||
| Basic and Diluted Loss per Common Share (in dollars per share) | $ (0.02) | $ (0.10) | ||||||
| ||||||||